Versant Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Versant Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2K	Sell	117 -49	-30%	-$5.02K	﹤0.01%	2195
2026 Q1	$18.1K	Buy	+166	New	+$15.8K	﹤0.01%	1866
2023 Q3	–	Sell	-12	Closed	-$807	–	2005
2023 Q2	$807	Buy	+12	New	+$732	﹤0.01%	1675
2020 Q1	–	Sell	-10	Closed	–	–	1519
2019 Q4	$0	Hold	10	–	–	﹤0.01%	1481
2019 Q3	$0	Hold	10	–	–	﹤0.01%	1490
2019 Q2	$0	Sell	10 -7	-41%	-$195	﹤0.01%	1567
2019 Q1	$0	Buy	+17	New	+$454	﹤0.01%	1662

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Versant Capital Management's LMAT Position: Q2 2026 in Review

Versant Capital Management reduced its LeMaitre Vascular (LMAT) stake by 30% in Q2 2026, selling an estimated $5.02K and leaving 117 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2195.

Versant Capital Management first reported a position in LMAT in Q1 2019 and has held it in 7 quarters since. The position peaked at $18.1K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Versant Capital Management held 117 shares of LeMaitre Vascular worth $11.2K as of Q2 2026.
Versant Capital Management sold 49 LeMaitre Vascular shares in Q2 2026, an estimated $5.02K.
LeMaitre Vascular made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2195 holding.
Versant Capital Management first reported a position in LeMaitre Vascular in Q1 2019 and has held it in 7 quarters since.
Versant Capital Management's LeMaitre Vascular position peaked at $18.1K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.